Malignant mesothelioma is an aggressive disease and is usually not detected until it has reached the advanced stages of cancer. Because of this, the prognosis a patient receives is usually not favorable. The average survival rate after a diagnosis of mesothelioma is only a year or two. However, treatments are getting better every day and the prognosis is improving. Cases that appear to be hopeless sometimes turn out to be not quite so bleak. Many survivors have lived much longer than their prognosis, and about 37 percent of those younger than 45 at the time of diagnosis survived for more than five years after they were diagnosed.

The best way to start Improving your prognosis and life expectancy is to find a mesothelioma specialist with experience in treating your particular form of the disease and start assessing the various mesothelioma treatment options immediately.

The best way to start Improving your prognosis and life expectancy is to find a mesothelioma specialist with experience in treating your particular form of the disease and start assessing the various mesothelioma treatment options immediately.

Picture used as a sectional page divider.

Mesothelioma Prognosis: Ways To Improve

The prognosis for people diagnosed with mesothelioma depends on several factors. The patient’s age, the stage of cancer, the location of cancer, gender, history of asbestos exposure and overall health are all determining factors. Other important factors include the type of cancer, whether cancer has spread and the cellular subtype of cancer.

These same factors will also determine the treatments the doctor will recommend for the patient.

The Location

The site of mesothelioma is what determines how it is classified. Pleural Mesothelioma attacks the lining of the lung and is most common. It makes up about 80 percent of all mesothelioma cases and has the best survival rates. Peritoneal mesothelioma is the lining of the abdomen. It accounts for about 10-15 percent of mesothelioma cases and is usually harder to treat. Pericardial and testicular mesothelioma are very rare.

Location of mesothelioma cancer as a factor of prognosis.
Picture used as a sectional page divider.

Stage of the disease

A patient’s mesothelioma prognosis also largely depends on how early the mesothelioma was diagnosed and how quickly treatment can begin. Mesothelioma has a very long latency period, and it is typical for the patient not to be diagnosed until it has reached stage 3 or 4. These are the stages when symptoms appear and a person seeks treatment. Since the symptoms are similar to many other respiratory problems like pneumonia and the flu, mesothelioma is often misdiagnosed at its earlier stages.

Picture used as a sectional page divider.


This refers to how far cancer has spread. Often by the time the patient sees an oncologist cancer has metastasized, or spread, from the tumor where it began to other parts of the body such as organs and lymph nodes. Treatment is determined by the extent of the metastases.

Picture used as a sectional page divider.

Patient Health

Those who are older and have problems with their health do not live as long as their younger and stronger counterparts. Heart disease, high blood pressure, and diabetes make it harder to treat mesothelioma. Traditional cancer treatments including mesothelioma surgery and radiation are a risk which limits the treatment options available to the patient.

Dr. Meso and colleagues examining the health of mesothelioma patient.
Picture used as a sectional page divider.

Ways To Improve Life Expectancy

When doctor’s speak to patients about their mesothelioma prognosis, life expectancy is also the biggest topic of discussion. There are many factors when it comes to determining life expectancy. One of the primary keys of predicting how many months or years a patient has is the stage of cancer.  There are 4 stages of mesothelioma, scientifically labeled as Stage I, II, III, IV.

Battling mesothelioma is a long process, but some things can be done to help improve both quality of life and the patient’s life expectancy. Although some important factors such as age and cancer stage cannot be changed, there are other ways that a patient’s prognosis can be improved upon. Those who have survived credit their survival to multimodal therapy, good nutrition, and medicines. A patient should take advantage of all the factors that are within their control.  Click the button below to learn more.

Top 10 Best Mesothelioma Cancer Centers

Visit Them Now
Picture used as a sectional page divider.

Take Control Of Your Mesothelioma Prognosis

With the research over the last decade, more treatment options have become available to patients than ever before. The most curative treatment available for pleural mesothelioma is surgery with radiation. Patients who undergo this treatment beat their prognosis by over two years. Peritoneal patients who are treated with heated intraperitoneal chemotherapy can outlive the prognosis by 24 months to 7 years.

For patients who are not eligible for surgery, traditional cancer treatments such as chemotherapy and radiation are available.

Another crucial factor that will have some determination on the prognosis is choosing a provider. Patients have complete control over their provider and selecting a mesothelioma specialist is essential. Specialists are specifically trained and have many years of experience in conducting research and treating mesothelioma patients. Specialists have expertise in their field and help the patient improve upon a dire prognosis.

Enrolling in clinical trials is another way to achieve a more favorable prognosis. Clinical trials are studies that are testing the latest therapies and often are more effective than the current options for treatment.

Staying healthy will help the body to be able to defend itself. When the immune system is healthy, it can handle cancer treatments such as chemotherapy and still fight off any diseases that could make recovery more difficult. Improving prognosis through maintaining personal health is essential to a positive outcome. The patient should make healthy choices through diet and exercise to increase their life expectancy.

Getting a second opinion is also a factor within a patient’s control. They are imperative as a second opinion can often help a patient gain access to treatments that were not available before. Sometimes doctors have different ideas on treatment, and some will offer treatments that others did not if they think the benefits outweighs the cost.

There is only a limited amount of time in which a patient can take lifesaving action and fight mesothelioma. It is important to know what mesothelioma treatments are available right away, and only a specialist can give patients the treatment that will be most beneficial to them.

New research, new chemotherapy drugs, and new therapies improve the prognosis for mesothelioma every day and provides hope for a better outcome to patients and their families.

Last Modified:Apr 14, 2017 @ 12:05 am


  • American Cancer Society. (2015, May 18). What are the key statistics of malignant mesothelioma? Retrieved from
  • Lindenmann, J., Matzi, V., Neuboeck, N., et al. Multimodal therapy of malignant pleural mesothelioma: Is the replacement of radical surgery imminent? Interactive CarioVascular and Thoracic Surgery. 2012; 16:237-243. doi: 10.1093/icvts/ivs465
  • Leuzzi, G., Rea, F., Spaggiari, L., et al. Prognostic score of long-term survival after surgery for malignant pleural mesothelioma: A multicenter analysis. Ann Thorac Surg. 2015; doi: 10.1016/j.athoracsur.2015.04.087
  • Sugarbaker, D.J., et al. (2011). Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg., 40(2): 298-303. doi: 10.1016/j.ejcts.2010.12.024. Retrieved from
  • Rusch VW, Giroux D, Kennedy C, et al. Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database. Journal of Thoracic Oncology. 2012;7(11):1631-1639. doi:10.1097/JTO.0b013e31826915f1
  • 2Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. Mar-Apr 2008;28(2):583-607; quiz 621-582. doi:10.1148/rg.282075175
  • 3Alexander HR, Burke AP. Diagnosis and management of patients with malignant peritoneal mesothelioma. Journal of Gastrointestinal Oncology. 2016;7(1):79-86. doi:10.3978/j.issn.2078-6891.2015.134
  • 4Cerruto CA, Brun EA, Chang D, Sugarbaker PH. Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. Arch Pathol Lab Med. Nov 2006;130(11):1654-1661. doi:10.1043/1543-2165(2006)130[1654:psohpi];2
  • 5Curran D, Sahmoud T, Therasse P, van Meerbeeck J, Postmus PE, Giaccone G. Prognostic factors in patients with pleural mesothelioma: the European Organization for Research and Treatment of Cancer experience. J Clin Oncol. Jan 1998;16(1):145-152.
  • 6Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. Mar 1998;113(3):723-731.
  • 7Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. Journal of Thoracic Oncology. 2007;2(10):957-965.
  • 8Frost G, Darnton A, Harding A-H. The Effect of Smoking on the Risk of Lung Cancer Mortality for Asbestos Workers in Great Britain (1971–2005). Annals of Occupational Hygiene. April 1, 2011 2011;55(3):239-247. doi:10.1093/annhyg/meq089
  • 10.1016/j.athoracsur.2015.04.087Tanrikulu, Abdullah Cetin, et al. “The Value of New Inflammatory Parameters in Malignant Mesothelioma Prognosis.” Acta Medica Mediterranea. 2015;31(9):9-15.
Picture used as a sectional page divider.

Need more information?

4 + 7 =

You Can Ask Us Anything.

6 + 7 =

Picture used as a sectional page divider.

Any medical or health advice provided and hosted on this site has been approved & edited by a team of registered nurses. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and the patient's/site visitor's physician. pledges to respect the legal requirements for medical information confidentiality as well as all personal information, including identity. Our Disclaimer | Our Mission

Pin It on Pinterest

Share This